Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Agios Pharmaceuticals Inc (8AP.MU)

25.80
+0.20
+(0.78%)
At close: April 29 at 8:00:36 AM GMT+2
Loading Chart for 8AP.MU
  • Previous Close 25.60
  • Open 0.00
  • Bid 25.40 x --
  • Ask 25.60 x --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 58.00
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 1, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 8AP.MU

View More

Performance Overview: 8AP.MU

Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

8AP.MU
19.88%
S&P 500 (^GSPC)
5.45%

1-Year Return

8AP.MU
12.24%
S&P 500 (^GSPC)
8.69%

3-Year Return

8AP.MU
18.35%
S&P 500 (^GSPC)
34.58%

5-Year Return

8AP.MU
36.72%
S&P 500 (^GSPC)
89.18%

Compare To: 8AP.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8AP.MU

View More

Valuation Measures

Annual
As of 4/28/2025
  • Market Cap

    1.51B

  • Enterprise Value

    774.73M

  • Trailing P/E

    2.49

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    46.05

  • Price/Book (mrq)

    1.09

  • Enterprise Value/Revenue

    24.08

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8AP.MU

View More

Company Insights: 8AP.MU

Research Reports: 8AP.MU

View More